Latest News
From the Journals
Frankincense extract may reduce disease activity in relapsing-remitting MS
Safety results and potential efficacy point to possible future clinical development.
Daily News Podcast
MDedge Daily News: Is kratom the answer to the opioid crisis?
And specialists have adverse reactions to drug price proposals.
From the Journals
In utero exposure to valproate and other AEDs linked to low test scores
Antiepileptic drugs taken in pregnancy take a toll on children’s educational achievement.
From the Journals
Office-based screen predicts dementia in Parkinson’s disease
An eight-item, in-office screening tool is as effective as biomarker-based screening in predicting the risk of dementia in Parkinson’s disease.
Feature
Drug pricing proposals raise red flags with specialists
Nine specialty medical organizations highlighted four recent proposals that could have an unintended consequence of limiting access.
Feature
Early diagnosis of Alzheimer’s could save U.S. trillions over time
Diagnosing 88% of Alzheimer’s patients in the mild cognitive impairment stage would save $7 trillion over U.S. citizens’ lifetime.
Conference Coverage
VIDEO: PFO closure device 100% effective against future strokes
ORLANDO – No patients who received a patent foramen ovale closure device experienced recurrent stroke, major bleeding, or vascular-related death...
Feature
Is kratom the answer to the opioid crisis?
Addiction experts say evidence remains sparse about the safety of the botanical product from Southeast Asia.
Daily News Podcast
MDedge Daily News: Treating H. pylori slashed new gastric cancers
And the Supreme Court considers California’s abortion speech law.
From the Journals
Siponimod trial ‘first’ to show delayed disability in secondary progressive MS
But the absolute difference in the rate of confirmed disability progression versus placebo was small.
Feature
‘Right to try’ bill passes House
The bill passed despite opposition from a broad coalition of physician and patient groups.